Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45

Collection

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

(Source Link)

Risk warning

2026-04-09 17:18

Li Hua Yi: Continue to be optimistic about this rebound, there is currently no reason to take profits

2026-04-17 21:53

Payward plans to acquire Bitnomial for $550 million, accelerating its layout in the U.S. compliant derivatives market

2026-04-17 20:18

Binance launches SOON trading competition, sharing a reward equivalent to $150,000

2026-04-17 19:02